The Reality of AI in Medical Writing Today

The Reality of AI in Medical Writing Today

Photo: Mikhail Nilov / Pexels

Over the past 18 months, I’ve integrated ChatGPT into my clinical documentation workflow across pharmaceutical projects. The results have been transformativeโ€”not in the way Silicon Valley promises, but in practical, measurable ways that compress timelines and reduce cognitive load on routine writing tasks.

Let me be direct: ChatGPT won’t replace clinical pharmacologists or medical writers. It can’t. But it will fundamentally change how you spend your time. Instead of drafting the seventh SOP iteration from scratch, you’ll spend your expertise on strategic review, regulatory interpretation, and quality assurance. That’s not a lossโ€”that’s leverage.

โš ๏ธ
Critical Disclaimer: AI as Assistant, Not Authority

ChatGPT is a content generation tool, not a clinical decision-maker. Everything produced by ChatGPT requires human expert review before any clinical, regulatory, or patient-facing use. AI cannot be a final regulatory submission without clinical professional sign-off. GCP compliance, data integrity, and audit trail requirements remain your responsibility entirely.

What ChatGPT Can Actually Help With

What ChatGPT Can Actually Help With

Photo: Brett Jordan / Pexels

After extensive testing in real workflows, here are the applications where ChatGPT provides genuine, measurable value:

๐Ÿ“‹

Clinical Study Reports

Draft narrative sections, adverse event summaries, and Discussion sections from your clinical data and protocol template.

๐Ÿ“„

SOPs and Protocols

Rapid iteration on workflow documentation, regulatory language templating, and revision management across multiple versions.

๐Ÿ‘ค

Patient Narratives

Generate initial narrative case summaries capturing key clinical eventsโ€”then edit with clinical judgment and actual data.

๐Ÿ“Š

Data Summaries

Synthesize laboratory values, vital signs, and demographic tables into narrative form for regulatory documents.

๐Ÿ›๏ธ

Regulatory Structure

ICH E3 formatting, CTD section organization, compliance checklists, and regulatory correspondence drafts.

โœ…

QA and Review

Grammar/style review, consistency checking across document sections, and formatting verification against templates.

What ChatGPT Cannot and Should Not Do

What ChatGPT Cannot and Should Not Do

Photo: KoolShooters / Pexels

Understanding these hard limits prevents costly mistakes in production workflows:

  • Verify citations: ChatGPT regularly invents references, journal names, and regulatory guidance numbers. It sounds confident while hallucinating. Never cite sources you haven’t independently verified.
  • Interpret actual patient data: AI cannot understand the clinical significance of individual safety events or protocol deviations in your specific trial context.
  • Handle confidential trial data: Never paste actual patient data, trial protocols, or confidential study information into ChatGPT. Data may be retained and used for training.
  • Make regulatory judgments: AI cannot decide whether an AE meets DSMB reporting criteria or represents a potential signal requiring expedited reporting.
  • Sign-off on final documents: AI outputs require expert human review and professional signature. This is non-negotiable in GCP-regulated environments.

Step 1: Setting Up ChatGPT for Medical Writing

Step 1: Setting Up ChatGPT for Medical Writing

Photo: David Bartus / Pexels

1

Choose the Right Model

Use GPT-4o or GPT-4โ€”not the free tier. ChatGPT 3.5 produces medical writing that sounds authoritative but contains factual errors at a much higher rate. GPT-4 has better instruction-following, lower hallucination rates, and superior handling of complex regulatory text.

2

Configure Custom Instructions

Navigate to Settings โ†’ Custom Instructions and add your medical writing system prompt. Set the AI’s role, terminology expectations, and key constraints before starting any document project. This consistency pays dividends across dozens of sessions.

Recommended Custom Instructions
You are assisting a clinical pharmacologist in medical writing for regulatory submissions.

Rules:
1. Flag when you cite any sourceโ€”explicit about whether it requires verification
2. NEVER invent citations, regulatory guidance, or approval dates
3. Use clinical terminology precisely; avoid oversimplification
4. Assume all output will be reviewed and edited by a clinical expert
5. Structure documents for ICH E3 / FDA / EMA standards as specified
6. Flag potential compliance issues or ambiguous language
7. Preserve scientific accuracy over accessible language
3

Organize Your Conversations

Create a new conversation for each document or project. This prevents context bleeding between unrelated documents. Title chats descriptively: “CSR Section 12.1 – Safety Summary” rather than “medical writing.” This makes your conversation history auditable.

Step 2: Writing Clinical Study Reports with AI Assistance

Step 2: Writing Clinical Study Reports with AI Assistance

Photo: Nothing Ahead / Pexels

CSRs are the most time-intensive regulatory documents. Here’s where AI helps without compromising accuracy:

A

Methods and Population Sections

These sections are largely protocol-derived. Ask ChatGPT to draft narrative descriptions from your protocol template. Prompt example:

Prompt โ€” CSR Population Section
I'm writing a CSR for a Phase 2b oncology trial. Here are my inclusion criteria:
[Paste your inclusion criteria]

Write 2-3 paragraphs describing the study population in regulatory style,
suitable for ICH E3 Section 1.2.1. Use past tense and formal terminology.
Flag ambiguous areas needing clinical team clarification.
B

Adverse Event Narratives

Never paste actual patient data into ChatGPT. Instead, provide clinical context and ask for narrative structure, then populate with actual de-identified data from your CDISC domains.

Prompt โ€” AE Narrative Template
Create an AE narrative template for a Grade 3 neutropenia event in a Phase 2
breast cancer trial. Include: onset date reference, relevant lab value fields
(without actual numbers), concomitant medications, dose modifications, and
outcome. Format for FDA regulatory submission. Mark all data fields as [TO BE
POPULATED WITH ACTUAL TRIAL DATA].

Step 3: SOPs and Clinical Protocol Writing

Step 3: SOPs and Clinical Protocol Writing

Photo: SHOX ART / Pexels

SOPs are ideal for AI assistance because they follow rigid structural templates and require clear, precise procedural language rather than clinical interpretation.

  • SOP revision cycles: Upload your existing SOP and ask ChatGPT to identify gaps, suggest updates for regulatory alignment, or restructure sections. Saves 70% of revision time on routine updates.
  • Protocol background sections: Ask ChatGPT to draft the scientific rationale, therapeutic area background, and unmet need sections from your compound summary.
  • Statistical analysis plans: Draft SAP narrative descriptions from your statistical model specificationsโ€”then have your biostatistician review for accuracy.
๐Ÿ“‹
Template Approach

Build a library of document templates with [SECTION PROMPTS] embedded. For each new project, fill in the trial-specific details and pass the template to ChatGPT for initial drafting. This creates reproducible, consistent output across projects.

Step 4: Patient Narratives and Safety Reports

Step 4: Patient Narratives and Safety Reports

Photo: Polina Zimmerman / Pexels

Patient narratives for safety reports require extreme care. The recommended workflow:

  1. Extract event timeline from your EDC system (de-identified)
  2. Summarize key clinical events in a structured list (no patient identifiers)
  3. Pass the summary to ChatGPT for narrative drafting
  4. Populate actual (de-identified) values and dates in the generated template
  5. Clinical expert review and sign-off mandatory before inclusion in any submission
โš ๏ธ
NEVER Use Real Patient Data

Patient safety narratives contain the most sensitive data in clinical research. Always work from de-identified summaries or anonymized templates. A data breach or privacy violation can result in FDA import alerts, ICH GCP violations, and serious legal liability.

Step 5: Regulatory Submissions and Correspondence

Step 5: Regulatory Submissions and Correspondence

Photo: ๐—›&๐—–๐—ข ใ€€ / Pexels

ChatGPT is surprisingly useful for regulatory correspondence when constrained correctly:

  • Response to information requests: Draft structured responses to FDA/EMA queries. AI provides the framework; you populate accurate data and review for regulatory accuracy.
  • Meeting request briefing documents: Generate Type B/C meeting request templates and pre-meeting package outlines.
  • Label writing: Draft initial proposed labeling sections (Indication, Dosage and Administration) from clinical program summaries.

Master Prompt Templates

Master Prompt Templates

Photo: Rahul Pandit / Pexels

These reusable prompts work across most medical writing tasks:

Prompt โ€” Regulatory Review
Review the following document section for:
1. ICH E3 / ICH E6 compliance issues
2. Ambiguous language that could be misinterpreted by regulators
3. Missing standard sections or headers
4. Inconsistent terminology
5. Claims that require citation

[Paste your document section]

Format response as: [Issue Type] | [Location] | [Recommendation]

Your Practical Workflow

Your Practical Workflow

Photo: Ann H / Pexels

Based on real implementation across multiple regulatory projects, here’s the workflow that maximizes AI value while maintaining GCP integrity:

  1. Define scope: List every document section, identify which are AI-draftable (methods, background) vs. judgment-intensive (Discussion, clinical conclusions)
  2. Build templates first: Create structured prompts for each section type before starting any document
  3. Draft with AI, audit with humans: Generate initial drafts quickly, then route through your standard clinical review process
  4. Document AI usage: Note which sections were AI-assisted in your audit trailโ€”regulators and journals increasingly require this
  5. Never skip sign-off: All AI-drafted content requires expert review and professional sign-off before submission
โœ…
Time Savings You Can Expect

Realistic estimates from my workflows: Methods sections (60% faster) ยท SOP revisions (70% faster) ยท AE narrative templates (50% faster) ยท Regulatory correspondence drafts (65% faster). Quality of AI drafts improves significantly as you refine your prompts over time.

Frequently Asked Questions

Frequently Asked Questions

Photo: Ann H / Pexels

Can AI-generated text be included in regulatory submissions?+

Yes, with appropriate human oversight and review. Regulators (FDA, EMA) do not prohibit AI assistance in document drafting, but they require that the final document is reviewed, verified, and signed off by qualified clinical professionals. The key is that AI-generated content must be validated against source data before submission.

How do I handle ChatGPT’s hallucinated citations?+

Never use any citation from ChatGPT without independently verifying it in PubMed, ClinicalTrials.gov, or the original source. Include a step in your review process to verify every reference. For regulatory submissions, use only citations from your verified study records and published literature you have directly accessed.

Should I disclose AI use in my submissions?+

Increasingly, yes. Many journals now require disclosure of AI use in manuscript preparation. For regulatory submissions, document AI assistance in your audit trail as part of your quality management system. Proactive transparency is always better than undisclosed use being discovered later.

Which GPT model should I use for medical writing?+

GPT-4o is the current recommendation. It has the lowest hallucination rate among accessible models, best instruction-following, and handles complex regulatory document structure well. GPT-4o-mini is acceptable for lower-stakes tasks like grammar review or SOP formatting, but use GPT-4o for CSRs, protocols, and regulatory correspondence.

K
Kedarinath Talisetty, CCDMยฎ
Clinical Pharmacologist & Medical Writer ยท AI Tool Clinic
Kedarinath has 12+ years of experience in clinical data management, oncology trials, and regulatory submissions. He helps pharmaceutical teams integrate AI tools into GCP-compliant documentation workflows.
K
Kedarinath Talisetty
CCDM® Certified · Clinical Data & AI Specialist
12+ years in clinical data management. Reviews AI tools through an evidence-based clinical lens to help healthcare professionals and businesses make informed decisions.